There’s been a lot of press talking about a new diet pill Qnexa this week.   Have you heard about it?   Basically it’s a diet pill that combines amphetamine phentermine, medication said to suppress appetite and approved for short term diet use, and Topamax, a medication said to increase satiety.   Many federal health advisors have been singing its praise this week and it was even voted in favor 20-2 from FDA doctors.   The next steps are a follow up study to make sure the drug doesn’t cause any heart problems. Excuse me you say?   Yes that’s right.   The FDA urges the company to conduct a folIow up study.    You see, Qnexa was rejected by the FDA in October 2010 because a study showed a higher heart rate in those who took Qnexa and birth defects for woman who became pregnant.   Although, the drug did yield an average of a 10% weight loss, the highest reduction noted by any “diet drug,” the FDA wants to be sure to follow up just to be sure...